Synthego is a biotechnology company that specializes in developing and producing synthetic ribonucleic acid (RNA) and single guide RNA (sgRNA) for use in gene editing. The company's products are used in research and development, drug discovery, and therapeutic applications. Synthego's proprietary platform, called CRISPRevolution, uses machine learning and automation to design and manufacture high-quality RNA products. The company was founded in 2012 by brothers Paul and Michael Dabrowski and is headquartered in Mountain View, California.